(Q40843452)

24 September 2017

title

Osteoclast differentiation factor in human osteosarcoma cell line (English)

1 reference

24 September 2017

0 references

Kinpara K

1

1 reference

24 September 2017

Mogi M

series ordinal

2

1 reference

24 September 2017

Kuzushima M

series ordinal

3

1 reference

24 September 2017

Togari A

series ordinal

4

1 reference

24 September 2017

publication date

1 November 2000

1 reference

24 September 2017

published in

Journal of Immunoassay

1 reference

24 September 2017

volume

21

1 reference

24 September 2017

issue

4

1 reference

24 September 2017

page(s)

327-340

1 reference

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F01971520009349540

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01971520009349540

IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01971520009349540

Involvement of nitric oxide and biopterin in proinflammatory cytokine-induced apoptotic cell death in mouse osteoblastic cell line MC3T3-E1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01971520009349540

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01971520009349540

10.1080/01971520009349540

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference